Norway Pharmaceutical and Medical Goods Expenditure Share
Norway Pharmaceutical and Medical Goods Expenditure Share published by Eurostat, covering Norway at annual frequency (2005–2022).
Norway (2022)
10.2
% of current health expenditure
-0.1pp YoY
YoY Change
-0.1pp
percentage points
Trend
down
Series length
18
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2022 | 10.2 | -0.1pp |
| 2021 | 10.2 | +0.1pp |
| 2020 | 10.1 | -0.1pp |
| 2019 | 10.3 | -0.3pp |
| 2018 | 10.6 | -0.4pp |
| 2017 | 11.0 | +0.2pp |
| 2016 | 10.8 | -0.1pp |
| 2015 | 10.9 | +0.1pp |
| 2014 | 10.8 | -0.1pp |
| 2013 | 10.9 | -0.3pp |
| 2012 | 11.3 | -0.3pp |
| 2011 | 11.6 | -0.1pp |
| 2010 | 11.7 | +0.0pp |
| 2009 | 11.6 | -0.5pp |
| 2008 | 12.1 | -1.1pp |
| 2007 | 13.2 | -0.7pp |
| 2006 | 13.9 | -0.5pp |
| 2005 | 14.4 | n/a |
About this Dataset
Norway recorded 10.2 % of current health expenditure in 2022. The most recent year-on-year change was -0.1pp. The historical series (2005–2022) shows a peak of 14.4 in 2005 and a trough of 10.1 in 2020.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology ensuring cross-country comparability within the European statistical framework.
The chart above shows the full historical trend; the table below lists annual values with year-on-year changes.
Frequently Asked Questions
This indicator tracks norway pharmaceutical and medical goods expenditure share in Norway, published by Eurostat. Data covers 2005–2022 at annual frequency using harmonised methodology.
The most recent observation covers 2022. Eurostat typically publishes this series with a lag of several months after the reference period. Data is updated annual.
The series peaked at 14.4 % of current health expenditure in 2005 and reached its lowest recorded value of 10.1 in 2020. The latest reading of 10.2 in 2022 represents a year-on-year change of -0.1pp.